Option chain shows key data for Novonesis (Novozymes) B's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Novonesis (Novozymes) B.

Novonesis (Novozymes) B (OTC:NVZMY) Stock, Option Chain

Novozymes

NOVOZYMES UNSPN ADR

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

News

Intraday Update

Markets

Movers

Trading Ideas

AACTF

ABBRF

ADBE

ADUS

AEHR

AFGC

AGNC

AMXEF

AMXVF

APPF

APPN

APTO

ARCAY

ARCE

ARCVF

ASHTY

ASNB

ATGFF

ATRC

ATVI

AZRE

BCYC

BILI

BLDP

BOWFF

BURL

BWXT

BXMT

CDLX

CDPYF

CEVA

CFBK

CFFA

CLGX

CLHRF

CLPBF

CLPBY

CMCLF

CMLEF

CMXHF

CNNE

COST

CPRT

CPWHF

CTAS

CTXXF

CWEN

CWEN-A

CWST

DBOEY

DIMC

DLT RESOLUTION INC by DLT Resolution Inc.

DLTI

DNNGY

DOCU

DOOR

DRTGF

EDPFY

Stocks That Hit 52-Week Highs On Tuesday

AAON

AAXN

ABBV

ACGL

ACIA

ACLS

AGRX

AGYS

AIQUY

AJRD

Allianz Ag Muenchen Namen-Akt Vinkuliert Shares

ALIZF

ALKEF

ALPMY

AMED

AMWD

AMZN

APAM

ARCC

ARES

ARKR

ARNC

ASHTF

ASML

ASMLF

ASND

BFAM

Brighthouse Financial, Inc. - Common Stock

BILL

BNTGF

BPUZF

BRLXF

BTCY

BWMC

CBRE

CCXI

CCYC

CHCT

CHDN

CHGCY

CNRMF

ABLZF

ACDSF

ACRE

ADCOF

ADNT

ADSK

ADYEY

ALEC

ALFVY

ALLE

AMRC

ANSS

ASPU

BCPC

BESIY

BFST

BKOR

BMRMF

BROG

BTAI

BTDPY

CBSH

CCLAY

CCOEY

CDAY

CERN

CGEN

CIFAF

CNSWF

CSGP

DDOG

DOOO

DPDW

DSGX

ENAKF

ENBP

ENPH

EPAM

Eaton Vance Tax-Advantaged Global Dividend

Stocks That Hit 52-Week Highs On Wednesday

Novonesis (Novozymes) B

Novozymes (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NVZMY#OTC">NVZMY</a>) reported its Q4 earnings results on Thursday, February 1, 2024 at 03:00 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Novozymes missed estimated earnings by 18.18%, reporting an EPS of $0.36 versus an estimate of $0.44.
Revenue was up $58.13 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.07 which was followed by a 2.66% increase in the share price the next day.
Here's a look at Novozymes's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.42</td>
<td>0.42</td>
<td>0.44</td>
<td>0.41</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.49</td>
<td>0.32</td>
<td>0.41</td>
<td>0.43</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>634.28M</td>
<td>632.02M</td>
<td>662.60M</td>
<td>671.94M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>650.51M</td>
<td>616.52M</td>
<td>666.31M</td>
<td>606.10M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Novozymes <a href="https://www.benzinga.com/quote/NVZMY/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

NVZMY

Recap: Novozymes Q4 Earnings

Novozymes (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NVZMY#OTC">NVZMY</a>) is set to give its latest quarterly earnings report on Thursday, 2023-10-26. Here's what investors need to know before the announcement.
Analysts estimate that Novozymes will report an earnings per share (EPS) of $0.42. 
Novozymes bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company missed EPS by $0.10, which was followed by a 2.01% increase in the share price the next day.
Here's a look at Novozymes's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.42</td>
<td>0.44</td>
<td>0.41</td>
<td>0.62</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.32</td>
<td>0.41</td>
<td>0.43</td>
<td>0.56</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.01%</td>
<td>0.0%</td>
<td>-0.35%</td>
<td>2.65%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1698264046_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Novozymes were trading at $39.75 as of October 24. Over the last 52-week period, shares are down 25.56%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/NVZMY/earnings">To track all earnings releases for Novozymes visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Novozymes Earnings Preview

Novozymes (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NVZMY#OTC">NVZMY</a>) is set to give its latest quarterly earnings report on Wednesday, 2023-04-26. Here's what investors need to know before the announcement.
Analysts estimate that Novozymes will report an earnings per share (EPS) of $0.44. 
Novozymes bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.02, which was followed by a 0.35% drop in the share price the next day.
Here's a look at Novozymes's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
<th>Q2 2022</th>
<th>Q1 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.41</td>
<td>0.62</td>
<td></td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.43</td>
<td>0.56</td>
<td>0.42</td>
<td>0.45</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-0.35%</td>
<td>2.65%</td>
<td>0.83%</td>
<td>1.02%</td>
</tr>
</tbody>
</table>

<h3>Stock Performance</h3>
Shares of Novozymes were trading at $54.69 as of April 24. Over the last 52-week period, shares are down 21.07%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/NVZMY/earnings">To track all earnings releases for Novozymes visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Novozymes's Earnings: A Preview

Novozymes (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NVZMY#OTC">NVZMY</a>) is set to give its latest quarterly earnings report on Thursday, 2023-01-26. Here's what investors need to know before the announcement.
Analysts estimate that Novozymes will report an earnings per share (EPS) of $0.41. 
Novozymes bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.06, which was followed by a 2.65% increase in the share price the next day.
Here's a look at Novozymes's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2022</th>
<th>Q2 2022</th>
<th>Q1 2022</th>
<th>Q4 2021</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.62</td>
<td></td>
<td></td>
<td>0.36</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.56</td>
<td>0.42</td>
<td>0.45</td>
<td>0.34</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.65%</td>
<td>0.83%</td>
<td>1.02%</td>
<td>-0.03%</td>
</tr>
</tbody>
</table>

<h3>Stock Performance</h3>
Shares of Novozymes were trading at $51.32 as of January 24. Over the last 52-week period, shares are down 25.23%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/NVZMY/earnings">To track all earnings releases for Novozymes visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For Novozymes

<h3>Companies Reporting Before The Bell</h3>
&bull; Brinker International Inc. (NYSE:<a class="ticker" href="/stock/EAT#NYSE">EAT</a>) is expected to report quarterly loss at $1.43 per share on revenue of $571.05 million.
&bull; Applied Industrial Tech Inc. (NYSE:<a class="ticker" href="/stock/AIT#NYSE">AIT</a>) is estimated to report quarterly earnings at $0.66 per share on revenue of $739.09 million.
&bull; APi Gr Inc. (NYSE:<a class="ticker" href="/stock/APG#NYSE">APG</a>) is expected to report earnings for its second quarter.
&bull; Arcos Dorados Holdings Inc. (NYSE:<a class="ticker" href="/stock/ARCO#NYSE">ARCO</a>) is estimated to report quarterly loss at $0.37 per share on revenue of $248.33 million.
&bull; Aerpio Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="/stock/ARPO#NASDAQ">ARPO</a>) is expected to report earnings for its second quarter.
&bull; CAE Inc. (NYSE:<a class="ticker" href="/stock/CAE#NYSE">CAE</a>) is estimated to report quarterly earnings at $0.25 per share on revenue of $611.18 million.
&bull; Coca-Cola Bottlers Japan Inc. (OTC:<a class="ticker" href="/stock/CCOJY#OTC">CCOJY</a>) is estimated to report earnings for its second quarter.
&bull; Crown Crafts Inc. (NASDAQ:<a class="ticker" href="/stock/CRWS#NASDAQ">CRWS</a>) is estimated to report quarterly earnings at $0.08 per share on revenue of $15.60 million.
&bull; China Yuchai Intl Inc. (NYSE:<a class="ticker" href="/stock/CYD#NYSE">CYD</a>) is expected to report quarterly earnings at $0.62 per share on revenue of $714.82 million.
&bull; CYREN Inc. (NASDAQ:<a class="ticker" href="/stock/CYRN#NASDAQ">CYRN</a>) is expected to report quarterly loss at $0.05 per share on revenue of $9.52 million.
&bull; DarioHealth Inc. (NASDAQ:<a class="ticker" href="/stock/DRIO#NASDAQ">DRIO</a>) is expected to report quarterly loss at $1.40 per share on revenue of $1.55 million.
&bull; Eltek Inc. (NASDAQ:<a class="ticker" href="/stock/ELTK#NASDAQ">ELTK</a>) is estimated to report earnings for its second quarter.
&bull; Kamada Inc. (NASDAQ:<a class="ticker" href="/stock/KMDA#NASDAQ">KMDA</a>) is expected to report quarterly earnings at $0.11 per share on revenue of $36.37 million.
&bull; OneSpaWorld Holdings Inc. (NASDAQ:<a class="ticker" href="/stock/OSW#NASDAQ">OSW</a>) is expected to report quarterly loss at $0.19 per share on revenue of $230.00 thousand.
&bull; Royalty Pharma Inc. (NASDAQ:<a class="ticker" href="/stock/RPRX#NASDAQ">RPRX</a>) is estimated to report quarterly earnings at $0.61 per share on revenue of $468.96 million.
&bull; ReWalk Robotics Inc. (NASDAQ:<a class="ticker" href="/stock/RWLK#NASDAQ">RWLK</a>) is expected to report quarterly loss at $0.27 per share on revenue of $800.00 thousand.
&bull; Tufin Software Inc. (NYSE:<a class="ticker" href="/stock/TUFN#NYSE">TUFN</a>) is expected to report quarterly loss at $0.29 per share on revenue of $21.94 million.
&bull; XPEL Inc. (NASDAQ:<a class="ticker" href="/stock/XPEL#NASDAQ">XPEL</a>) is estimated to report earnings for its second quarter.
&bull; Brainsway Inc. (NASDAQ:<a class="ticker" href="/stock/BWAY#NASDAQ">BWAY</a>) is expected to report quarterly loss at $0.13 per share on revenue of $4.77 million.
&bull; PGT Innovations Inc. (NYSE:<a class="ticker" href="/stock/PGTI#NYSE">PGTI</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $192.70 million.
&bull; Pan Pacific International Inc. (OTC:<a class="ticker" href="/stock/DQJCY#OTC">DQJCY</a>) is expected to report earnings for its fourth quarter.
&bull; Lemonade Inc. (NYSE:<a class="ticker" href="/stock/LMND#NYSE">LMND</a>) is expected to report quarterly loss at $0.95 per share on revenue of $29.31 million.
&bull; Performance Food Group Inc. (NYSE:<a class="ticker" href="/stock/PFGC#NYSE">PFGC</a>) is expected to report quarterly loss at $0.24 per share on revenue of $5.43 billion.
&bull; Freehold Royalties Inc. (OTC:<a class="ticker" href="/stock/FRHLF#OTC">FRHLF</a>) is estimated to report earnings for its second quarter.
&bull; Jumia Technologies Inc. (NYSE:<a class="ticker" href="/stock/JMIA#NYSE">JMIA</a>) is expected to report quarterly loss at $0.71 per share on revenue of $37.20 million.
&bull; SECOM Co Inc. (OTC:<a class="ticker" href="/stock/SOMLY#OTC">SOMLY</a>) is expected to report earnings for its first quarter.
&bull; Aleafia Health Inc. (OTC:<a class="ticker" href="/stock/ALEAF#OTC">ALEAF</a>) is expected to report earnings for its second quarter.
&bull; Novozymes Inc. (OTC:<a class="ticker" href="/stock/NVZMY#OTC">NVZMY</a>) is estimated to report earnings for its second quarter.
&nbsp;
<h3>Companies Reporting After The Bell</h3>
&bull; CACI International Inc. (NYSE:<a class="ticker" href="/stock/CACI#NYSE">CACI</a>) is expected to report quarterly earnings at $3.44 per share on revenue of $1.47 billion.
&bull; ClearPoint Neuro Inc. (NASDAQ:<a class="ticker" href="/stock/CLPT#NASDAQ">CLPT</a>) is expected to report quarterly loss at $0.16 per share on revenue of $1.88 million.
&bull; KemPharm Inc. (OTC:<a class="ticker" href="/stock/KMPH#OTC">KMPH</a>) is expected to report earnings for its second quarter.
&bull; ATA Creativity Global Inc. (NASDAQ:<a class="ticker" href="/stock/AACG#NASDAQ">AACG</a>) is estimated to report earnings for its second quarter.
&bull; Aspen Technology Inc. (NASDAQ:<a class="ticker" href="/stock/AZPN#NASDAQ">AZPN</a>) is expected to report quarterly earnings at $1.17 per share on revenue of $176.57 million.
&bull; Brickell Biotech Inc. (NASDAQ:<a class="ticker" href="/stock/BBI#NASDAQ">BBI</a>) is estimated to report earnings for its second quarter.
&bull; Biocept Inc. (NASDAQ:<a class="ticker" href="/stock/BIOC#NASDAQ">BIOC</a>) is expected to report earnings for its second quarter.
&bull; Blue Bird Inc. (NASDAQ:<a class="ticker" href="/stock/BLBD#NASDAQ">BLBD</a>) is estimated to report quarterly earnings at $0.21 per share on revenue of $226.20 million.
&bull; BRF Inc. (NYSE:<a class="ticker" href="/stock/BRFS#NYSE">BRFS</a>) is estimated to report quarterly earnings at $0.10 per share on revenue of $1.94 billion.
&bull; Ballantyne Strong, Inc. Common Stock Inc. (AMEX:<a class="ticker" href="/stock/BTN#AMEX">BTN</a>) is estimated to report earnings for its second quarter.
&bull; Conifer Holdings Inc. (NASDAQ:<a class="ticker" href="/stock/CNFR#NASDAQ">CNFR</a>) is expected to report quarterly loss at $0.06 per share on revenue of $21.52 million.
&bull; Cisco Systems Inc. (NASDAQ:<a class="ticker" href="/stock/CSCO#NASDAQ">CSCO</a>) is estimated to report quarterly earnings at $0.74 per share on revenue of $12.08 billion.
&bull; Cyclacel Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="/stock/CYCC#NASDAQ">CYCC</a>) is estimated to report earnings for its second quarter.
&bull; Dare Bioscience Inc. (NASDAQ:<a class="ticker" href="/stock/DARE#NASDAQ">DARE</a>) is expected to report quarterly loss at $0.15 per share on revenue of $210.00 thousand.
&bull; EnerSys Inc. (NYSE:<a class="ticker" href="/stock/ENS#NYSE">ENS</a>) is estimated to report quarterly earnings at $0.67 per share on revenue of $693.74 million.
&bull; Eton Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="/stock/ETON#NASDAQ">ETON</a>) is estimated to report quarterly loss at $0.26 per share on revenue of $290.00 thousand.
&bull; Evolving Systems Inc. (NASDAQ:<a class="ticker" href="/stock/EVOL#NASDAQ">EVOL</a>) is estimated to report earnings for its second quarter.
&bull; Eyenovia Inc. (NASDAQ:<a class="ticker" href="/stock/EYEN#NASDAQ">EYEN</a>) is estimated to report earnings for its second quarter.
&bull; Fossil Group Inc. (NASDAQ:<a class="ticker" href="/stock/FOSL#NASDAQ">FOSL</a>) is expected to report quarterly loss at $1.71 per share on revenue of $182.10 million.
&bull; None Inc. (None:GMXAY) is estimated to report earnings for its second quarter.
&bull; Helius Medical Inc. (NASDAQ:<a class="ticker" href="/stock/HSDT#NASDAQ">HSDT</a>) is expected to report earnings for its second quarter.
&bull; ImmuCell Inc. (NASDAQ:<a class="ticker" href="/stock/ICCC#NASDAQ">ICCC</a>) is expected to report quarterly loss at $0.10 per share on revenue of $3.00 billion.
&bull; Intercorp Financial Servs Inc. (NYSE:<a class="ticker" href="/stock/IFS#NYSE">IFS</a>) is estimated to report quarterly earnings at $0.39 per share on revenue of $317.00 million.
&bull; Lyft Inc. (NASDAQ:<a class="ticker" href="/stock/LYFT#NASDAQ">LYFT</a>) is estimated to report quarterly loss at $0.99 per share on revenue of $351.48 million.
&bull; Brigham Minerals Inc. (NYSE:<a class="ticker" href="/stock/MNRL#NYSE">MNRL</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $13.13 million.
&bull; Neoleukin Therapeutics Inc. (NASDAQ:<a class="ticker" href="/stock/NLTX#NASDAQ">NLTX</a>) is estimated to report earnings for its second quarter.
&bull; 1Life Healthcare Inc. (NASDAQ:<a class="ticker" href="/stock/ONEM#NASDAQ">ONEM</a>) is expected to report quarterly loss at $0.33 per share on revenue of $61.72 million.
&bull; Onconova Therapeutics Inc. (NASDAQ:<a class="ticker" href="/stock/ONTX#NASDAQ">ONTX</a>) is expected to report quarterly loss at $0.03 per share on revenue of $170.00 thousand.
&bull; OpGen Inc. (NASDAQ:<a class="ticker" href="/stock/OPGN#NASDAQ">OPGN</a>) is estimated to report quarterly loss at $0.51 per share on revenue of $1.20 million.
&bull; OTC Markets Gr Inc. (OTC:<a class="ticker" href="/stock/OTCM#OTC">OTCM</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $14.30 million.
&bull; Pangaea Logistics Solns Inc. (NASDAQ:<a class="ticker" href="/stock/PANL#NASDAQ">PANL</a>) is expected to report quarterly loss at $0.14 per share on revenue of $75.40 million.
&bull; Points International Inc. (NASDAQ:<a class="ticker" href="/stock/PCOM#NASDAQ">PCOM</a>) is expected to report quarterly earnings at $0.13 per share on revenue of $89.15 million.
&bull; Peyto Exploration &amp; Dev Inc. (OTC:<a class="ticker" href="/stock/PEYUF#OTC">PEYUF</a>) is estimated to report earnings for its second quarter.
&bull; Ping Identity Holding Inc. (NYSE:<a class="ticker" href="/stock/PING#NYSE">PING</a>) is estimated to report quarterly earnings at $0.01 per share on revenue of $53.79 million.
&bull; Priority Tech Holdings Inc. (NASDAQ:<a class="ticker" href="/stock/PRTH#NASDAQ">PRTH</a>) is expected to report earnings for its second quarter.
&bull; Postal Realty Trust Inc. (NYSE:<a class="ticker" href="/stock/PSTL#NYSE">PSTL</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $5.12 million.
&bull; RiceBran Tech Inc. (NASDAQ:<a class="ticker" href="/stock/RIBT#NASDAQ">RIBT</a>) is expected to report quarterly loss at $0.06 per share on revenue of $9.05 million.
&bull; Revolve Group Inc. (NYSE:<a class="ticker" href="/stock/RVLV#NYSE">RVLV</a>) is expected to report quarterly earnings at $0.02 per share on revenue of $119.41 million.
&bull; SmileDirectClub Inc. (NASDAQ:<a class="ticker" href="/stock/SDC#NASDAQ">SDC</a>) is expected to report quarterly loss at $0.14 per share on revenue of $84.19 million.
&bull; Salarius Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="/stock/SLRX#NASDAQ">SLRX</a>) is expected to report quarterly earnings at $0.16 per share on revenue of $1.19 million.
&bull; SenesTech Inc. (NASDAQ:<a class="ticker" href="/stock/SNES#NASDAQ">SNES</a>) is estimated to report quarterly loss at $33.90 per share on revenue of $50.00 thousand.
&bull; Sonim Technologies Inc. (NASDAQ:<a class="ticker" href="/stock/SONM#NASDAQ">SONM</a>) is estimated to report quarterly loss at $0.27 per share on revenue of $14.90 million.
&bull; SpartanNash Inc. (NASDAQ:<a class="ticker" href="/stock/SPTN#NASDAQ">SPTN</a>) is expected to report quarterly earnings at $0.63 per share on revenue of $2.26 billion.
&bull; The One Group Hospitality Inc. (NASDAQ:<a class="ticker" href="/stock/STKS#NASDAQ">STKS</a>) is estimated to report quarterly loss at $0.20 per share on revenue of $9.80 million.
&bull; TransAtlantic Petroleum Ltd Ordinary Shares (Bermuda) Inc. (AMEX:<a class="ticker" href="/stock/TAT#AMEX">TAT</a>) is expected to report earnings for its second quarter.
&bull; TELA Bio Inc. (NASDAQ:<a class="ticker" href="/stock/TELA#NASDAQ">TELA</a>) is estimated to report quarterly loss at $0.59 per share on revenue of $1.93 million.
&bull; Green Organic Dutchman Inc. (OTC:<a class="ticker" href="/stock/TGODF#OTC">TGODF</a>) is estimated to report earnings for its second quarter.
&bull; Telenav Inc. (NASDAQ:<a class="ticker" href="/stock/TNAV#NASDAQ">TNAV</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $44.43 million.
&bull; Velocity Financial Inc. (NYSE:<a class="ticker" href="/stock/VEL#NYSE">VEL</a>) is estimated to report quarterly earnings at $0.21 per share on revenue of $18.20 million.
&bull; Viela Bio Inc. (NASDAQ:<a class="ticker" href="/stock/VIE#NASDAQ">VIE</a>) is estimated to report earnings for its second quarter.
&bull; Varex Imaging Inc. (NASDAQ:<a class="ticker" href="/stock/VREX#NASDAQ">VREX</a>) is expected to report quarterly loss at $0.01 per share on revenue of $171.09 million.
&bull; Vroom Inc. (NASDAQ:<a class="ticker" href="/stock/VRM#NASDAQ">VRM</a>) is estimated to report quarterly loss at $0.70 per share on revenue of $234.94 million.
&bull; Wheaton Precious Metals Inc. (NYSE:<a class="ticker" href="/stock/WPM#NYSE">WPM</a>) is expected to report quarterly earnings at $0.19 per share on revenue of $222.70 million.
&bull; Wayside Technology Group Inc. (NASDAQ:<a class="ticker" href="/stock/WSTG#NASDAQ">WSTG</a>) is expected to report earnings for its second quarter.
&bull; cbdMD, Inc. Common Stock Inc. (AMEX:<a class="ticker" href="/stock/YCBD#AMEX">YCBD</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $9.57 million.
&bull; JOYY Inc. (NASDAQ:<a class="ticker" href="/stock/YY#NASDAQ">YY</a>) is expected to report quarterly earnings at $0.69 per share on revenue of $737.45 million.
&bull; ZTO Express (Cayman) Inc. (NYSE:<a class="ticker" href="/stock/ZTO#NYSE">ZTO</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $920.47 million.

Comments

Novonesis (Novozymes) B

Novonesis (Novozymes) B (NVZMY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga